Here, we describe a pharmacogenetics technique that allows to selectively and reversibly inactivate LC neurons using Designer Receptors Exclusively Activated by Designer Medications (DREADD). We show which the expression of the hM4Di DREADD could be restricted to noradrenergic LC neurons and that the level of LC inhibition might be altered https://freshchesms.com/product/buy-deschloroetizolam-2mg-blotters/